Clinical trials
Patient Outcomes clinical trials
Below are recruiting patient outcomes clinical trials, each written for real people, not researchers. We’re tracking 678 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06118840Recruiting
AI tool for spotting brain aneurysms on CT scans
This trial tests if an AI model can help doctors detect brain aneurysms more accurately on head CT angiograms (CTA). It may lead to earlier treatment and better outcomes.
Hefei, AnhuiAges 18 years+ - NCT06151392RecruitingPhase 4
Probiotics and zinc for children with brain infection
This trial tests whether adding probiotics (healthy bacteria) and zinc supplements to standard treatment helps children with a brain infection called ventriculitis. It aims to see if these supplements improve recovery and reduce complications.
CairoAges 1 month–4 years - NCT06218472Recruiting
Early day hospital treatment for teens with anorexia
This study tests whether starting day hospital treatment early helps teenagers with anorexia nervosa improve their eating habits and supports their families. It is for adolescents who have had anorexia for less than one year and are not severely underweight.
Paris, IDFAges 12 years+ - NCT06338124Recruiting
Lab tests to predict outcomes in sepsis patients
This study looks at whether certain blood test results can help predict how well people with sepsis will do. Sepsis is a serious infection that can affect the whole body. You may be able to join if you have sepsis and are over 18.
AsyutAges 18–70 - NCT06365528Recruiting
Tunneled PICC line in adults in the hospital
This study looks at how well a tunneled PICC (a special long-term IV line) works in adults who need it while in the hospital. It aims to see if it reduces complications compared to standard PICCs, which could mean fewer problems for you.
Porto AlegreAges 18 years+ - NCT06513273Recruiting
New treatments for AML in the real world
This study looks at how well new AML medicines work in everyday medical practice, outside of clinical trials. If you are starting a newer AML drug like gilteritinib, an IDH inhibitor, oral azacytidine, or others, you may be able to join.
San Giovanni RotondoAges 18 years+ - NCT06535503Recruiting
Heart attack with shock: Study of patient outcomes in Abu Dhabi
This study looks at the medical records of people who had a severe heart attack (STEMI) that caused cardiogenic shock. Researchers want to understand how these patients did during their hospital stay to improve care in the future.
Abu Dhabi, Abu Dhabi EmirateAges 18 years+ - NCT06550063Recruiting
HER2 status in esophagogastric cancer and patient outcomes
This study looks back at medical records of people with a certain type of esophageal or stomach cancer to see how HER2 status relates to patient outcomes. It may help guide future treatment decisions.
Dublin, LeinsterAges Any age - NCT06558877Recruiting
Pharmacist-led program for better blood pressure control
This trial tests if a pharmacist-led program with regular follow-ups and support can help people with high blood pressure get better control over their condition. It may be a good fit if you have high blood pressure that is not well controlled despite taking medication.
Xi'an, ShaanxiAges 18–80 - NCT06563206Recruiting
Exergame and robotic therapy for stroke recovery
This study tests whether playing video games that involve movement (exergaming) or using a robotic arm device can help improve arm function and reduce inflammation after a stroke. It may be a good fit if you are ready to start therapy and can sit up and watch a screen.
Makassar, South SulawesiAges Any age - NCT06744985Recruiting
Comparing two scoring tools for trauma outcomes
This trial compares two scoring systems (RTS and MGAP) to see which one better predicts recovery, need for intensive care, or complications in people who arrive at the hospital within 6 hours of a traumatic injury.
BaghdadAges 18 years+ - NCT06828679Recruiting
AI system to improve arm recovery after stroke
This trial tests whether an AI-powered system can help improve arm movement in people who had a stroke 1 to 6 months ago. It uses electrical stimulation to activate muscles and may lead to better recovery.
Hong Kong, Sha TinAges 65–80 - NCT06838611Recruiting
Study of patients with severe tricuspid regurgitation
This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.
Warsaw, Masovian VoivodeshipAges 18 years+ - NCT06864819Recruiting
Alcohol blood test and surgery recovery study
This study looks at a blood test called phosphatidylethanol (PEth) to see if it can help predict how well you recover after surgery. It is for people who drink alcohol regularly and are having elective surgery with a longer hospital stay or ICU stay at University Hospitals Cleveland Medical Center.
Cleveland, OhioAges 21–79 - NCT06881238Recruiting
How hepatitis B affects inflammatory bowel disease
This study looks at how hepatitis B virus affects people with inflammatory bowel disease (IBD). It may help doctors better understand the link between the two conditions.
Tanta, GharbyeaAges 18 years+ - NCT06967532Recruiting
Using a virus to predict how well lung cancer treatment works
This study checks if a common virus (Torque Teno virus) can help predict how well immune checkpoint inhibitor therapy works for non-small cell lung cancer (NSCLC) and what happens after surgery. The goal is to find a better way to match treatment to patients.
ViennaAges 18 years+ - NCT07036874Recruiting
Predicting outcomes in liver cancer with non-invasive tests
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
Hong KongAges 18 years+ - NCT07051850Recruiting
Quality of life study for relapsed myeloma immunotherapy
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
Seocho, SeoulAges 19 years+ - NCT07185724RecruitingPhase 4
Ketorolac for fresh embryo transfer in IVF
This trial tests whether a medicine called ketorolac (a type of NSAID, similar to ibuprofen) can improve outcomes when you have a fresh embryo transfer during IVF. It may help reduce cramping or inflammation that could affect implantation.
Iowa City, IowaAges 18–37 - NCT07212699Recruiting
Knee osteoarthritis app-based outcome score study
This trial uses a smartphone app to track symptoms in people with knee osteoarthritis or a knee replacement. The goal is to develop a better way to measure how patients are doing.
Munich, BavariaAges 18 years+ - NCT07309497Recruiting
Geriatric Assessment for Older Adults Before CAR-T or Bispecific Therapy
This trial studies how a simple geriatric assessment (a check-up for older adults) can help predict side effects and outcomes in patients aged 65+ who are about to receive CAR-T cell therapy or bispecific antibody treatment.
BernAges 65 years+ - NCT07393412Recruiting
Heart and vessel disease study for Korean patients at Samsung Medical Center
This study looks at people who have visited Samsung Medical Center for heart or blood vessel problems. It aims to find what factors affect their health over time, which could help doctors predict and prevent future issues.
SeoulAges Any age - NCT02699736Enrolling by invitation
HIV and hepatitis C study in European adults
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
Buenos AiresAges 16 years+ - NCT07439159Recruiting
Heart ultrasound to predict outcomes in hospitalized heart failure
This study uses a heart ultrasound (echocardiogram) to predict outcomes in people hospitalized for sudden heart failure. If you are receiving IV fluid-removing medication, the results may help your doctors understand your condition better.
IstanbulAges 18 years+
Hear when a new Patient Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient outcomes?
- Yes. Clin2 currently lists 678 recruiting patient outcomes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient outcomes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient outcomes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.